Clinical Trial Update: Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction with oral fludarabine, mitoxantrone, and rituximab followed by rituximab maintenance in follicular B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Fludarabine (oral) (fludarabine)
• Mitoxantrone (mitoxantrone)
• Rituximab (rituximab)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Follicular T-NHL Lymphoma, Rituximab Maintenance | Phase 2 | Status: COMPLETED